Immunocore Holdings (Immunocore Holdings) EV-to-Revenue : 5.32 (As of May. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Immunocore Holdings's enterprise value is $1,848.1 Mil. Immunocore Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $347.3 Mil. Therefore, Immunocore Holdings's EV-to-Revenue for today is 5.32.

The historical rank and industry rank for Immunocore Holdings's EV-to-Revenue or its related term are showing as below:

IMCR' s EV-to-Revenue Range Over the Past 10 Years
Min: 5.57 Med: 17.52 Max: 40.54
Current: 5.59

During the past 6 years, the highest EV-to-Revenue of Immunocore Holdings was 40.54. The lowest was 5.57. And the median was 17.52.

IMCR's EV-to-Revenue is ranked better than
59.38% of 1039 companies
in the Biotechnology industry
Industry Median: 8.18 vs IMCR: 5.59

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Immunocore Holdings's stock price is $46.05. Immunocore Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $6.91. Therefore, Immunocore Holdings's PS Ratio for today is 6.66.

Immunocore Holdings EV-to-Revenue Historical Data

The historical data trend for Immunocore Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings EV-to-Revenue Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

25.67

10.87

9.04

Immunocore Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															7.94	9.19	7.77	9.04	7.89

Competitive Comparison of Immunocore Holdings's EV-to-Revenue

For the Biotechnology subindustry, Immunocore Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunocore Holdings's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunocore Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Immunocore Holdings's EV-to-Revenue falls into.

Immunocore Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Immunocore Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1848.141	/	347.329
	=	5.32

Immunocore Holdings's current Enterprise Value is $1,848.1 Mil.
Immunocore Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $347.3 Mil.

Immunocore Holdings (NAS:IMCR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Immunocore Holdings's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	46.05	/	6.911
	=	6.66

Immunocore Holdings's share price for today is $46.05.
Immunocore Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.91.

Immunocore Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.